We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
-4.03%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$29.4B
AUM Growth
-$873M
(-2.9%)
Cap. Flow
+$534M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
8.87%
Holding
3,036
New
582
Increased
766
Reduced
960
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$244M |
| 2 |
Enphase Energy
ENPH
|
+$229M |
| 3 |
GSK
GSK
|
+$223M |
| 4 |
Accenture
ACN
|
+$209M |
| 5 |
Citigroup
C
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$294M |
| 2 |
Amazon
AMZN
|
+$272M |
| 3 |
PayPal
PYPL
|
+$271M |
| 4 |
Bank of America
BAC
|
+$225M |
| 5 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 13.7% |
| 3 | Financials | 9.76% |
| 4 | Industrials | 8.72% |
| 5 | Consumer Discretionary | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
GeoVax Labs
GOVX
$3.58M
| $126K | ﹤0.01% |
309
-26
| -8% | -$15K |
|
|
SUP
2177
DELISTED
Superior Industries International
SUP
| $126K | ﹤0.01% |
41,887
-11,264
| -21% | -$49.7K |
|
|
EEX
2178
DELISTED
Emerald Holding
EEX
| $123K | ﹤0.01% |
36,352
-2,218
| -6% | -$8.02K |
|
|
KNTE
2179
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $123K | ﹤0.01% |
+10,258
| New | +$134K |
|
2180
Trevi Therapeutics
TRVI
$2.58B
| $122K | ﹤0.01% |
+79,437
| New | +$260K |
|
2181
Intellicheck
IDN
$58.6M
| $121K | ﹤0.01% |
47,924
-36,713
| -43% | -$94.5K |
|
2182
NSTS Bancorp
NSTS
$68.8M
| $120K | ﹤0.01% |
11,102
-3,300
| -23% | -$36.3K |
|
2183
Concrete Pumping Holdings
BBCP
$474M
| $119K | ﹤0.01% |
+18,422
| New | +$124K |
|
2184
Zedge
ZDGE
$37.8M
| $119K | ﹤0.01% |
50,265
-7,595
| -13% | -$21.8K |
|
|
SLAC
2185
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
| $118K | ﹤0.01% |
+12,000
| New | +$118K |
|
2186
Actinium Pharmaceuticals
ATNM
$32.9M
| $117K | ﹤0.01% |
15,826
-41,392
| -72% | -$257K |
|
2187
Orion Group Holdings
ORN
$369M
| $116K | ﹤0.01% |
43,948
-2,357
| -5% | -$6.19K |
|
|
DCFC
2188
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
| $116K | ﹤0.01% |
+183
| New | +$229K |
|
|
VNTR
2189
DELISTED
Venator Materials PLC
VNTR
| $116K | ﹤0.01% |
132,076
-96,807
| -42% | -$162K |
|
|
MAPS
2190
DELISTED
WM TECHNOLOGY INC A
MAPS
| $115K | ﹤0.01% |
+71,266
| New | +$202K |
|
2191
Nature's Sunshine
NATR
$252M
| $114K | ﹤0.01% |
13,881
-12,190
| -47% | -$121K |
|
|
NINE
2192
DELISTED
Nine Energy Service
NINE
| $114K | ﹤0.01% |
+43,037
| New | +$121K |
|
|
ONTF
2193
DELISTED
ON24
ONTF
| $114K | ﹤0.01% |
12,900
-88,070
| -87% | -$844K |
|
2194
Atossa Therapeutics
ATOS
$26.3M
| $112K | ﹤0.01% |
8,992
+3,943
| +78% | +$57.3K |
|
2195
Instil Bio
TIL
$53M
| $112K | ﹤0.01% |
1,157
-4,934
| -81% | -$564K |
|
|
AHT
2196
Ashford Hospitality Trust
AHT
$21.5M
| $110K | ﹤0.01% |
+1,621
| New | +$144K |
|
2197
Century Casinos
CNTY
$35.7M
| $109K | ﹤0.01% |
16,646
-2,554
| -13% | -$19.7K |
|
2198
Cumberland Pharmaceuticals
CPIX
$117M
| $109K | ﹤0.01% |
45,215
-6,287
| -12% | -$14.8K |
|
|
PSTX
2199
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $109K | ﹤0.01% |
+30,777
| New | +$102K |
|
2200
SELLAS Life Sciences
SLS
$2.89B
| $108K | ﹤0.01% |
53,685
+32,191
| +150% | +$88.9K |
|
Similar funds
John Overdeck's Q3 2022 Portfolio in Review
As of Q3 2022, John Overdeck held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
John Overdeck's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
- John Overdeck added most to GSK in Q3 2022, an estimated $223M increase.
- John Overdeck's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
- John Overdeck fully exited Bank of America in Q3 2022, selling an estimated $225M.
- John Overdeck's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
- John Overdeck opened 582 new positions and closed 600 in Q3 2022.
- John Overdeck's portfolio value fell 2.9% quarter-over-quarter to $29.4B.
Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.